NDC80基内托克组合组件是腺囊性癌的潜在分子标
Xia Yan1, Sumei He2, Yuansheng Lin3
1Department of Oncology, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine (Punan Hospital in Pudong), Shanghai 200125, P.R. China.
在腺囊性癌 (ACC) 中,NUF2 升级调节,促进瘤细胞的增殖和迁移. 这一发现表明NUF2是ACC的潜在治疗点,影响免疫细胞透.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 腺状囊性癌 (ACC) 是一种缓慢生长的恶性瘤,主要影响唾液腺.
- 在ACC病变发生过程中,NDC80基因组合组件NUF2的作用尚不清楚.
研究的目的:
- 研究NUF2在ACC中的表达和功能.
- 探索NUF2与ACC中的免疫细胞透之间的关联.
- 评估NUF2作为ACC的潜在治疗点.
主要方法:
- 使用GEO数据集进行基因表达分析 (GSE88804,GSE153002).
- 蛋白质与蛋白质相互作用网络的构建和枢纽基因的识别 (Cytoscape,cytoHubba).
- 不同表达式分析 (limma 包装, TIMER, GSE36820).
- 免疫细胞透分析 (ssGSEA).
- 在体外验证使用西式涂抹,免疫组织化学,siRNA,细胞计数套件-8和伤口愈合试验.
主要成果:
- 与正常组织相比,在ACC组织中发现NUF2显著上调.
- NUF2表达与ACC细胞的增多和迁移相关.
- NUF2与特定免疫细胞的透有关,包括激活的CD4+T细胞.
- 与NUF2相关的基因在与细胞迁移和细胞外矩阵相互作用相关的途径中得到了丰富.
结论:
- 在ACC中,NUF2是一个关键的上调基因,促进瘤的进展.
- 在ACC微环境中,NUF2在免疫细胞透中发挥作用.
- NUF2代表了腺囊性癌治疗的有前途的治疗标.
更多相关视频
12:28Protein Purification Technique that Allows Detection of Sumoylation and Ubiquitination of Budding Yeast Kinetochore Proteins Ndc10 and Ndc80
Published on: May 3, 2015
07:00Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
相关概念视频
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Components of Stress
Interestingly, the hidden cube faces also experience these stresses, equal and...
Components of Language
